Clinical Trials Browser

Phase 2 × Curcumin × 1 year × Clear all

NCT06063486 2026-02-02

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms

Phase 2 Recruiting

Myelodysplastic Syndromes, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT07248020 2025-11-25

BCMRECRAD

Phase 2 Not yet recruiting

Gastrointestinal

Rectal Neoplasms

NCT02782949 2025-09-15

Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia

Phase 2 Active not recruiting

50 enrolled 10 charts

Gastrointestinal

Gastritis, Atrophic, Stomach Neoplasms